Live Feeds

Source map — mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say

Every domain this feed has drawn corroborated signal from. We store facts and short excerpts and link back to originals — never republished article bodies.

SourceTypeTrust
CNBC news 60%
Bloomberg.com news 60%
The New York Times news 60%
Ars Technica news 60%
Yahoo Finance news 60%
www.nationalgeographic.com news 50%
www.smithsonianmag.com news 50%
www.medicalnewstoday.com news 50%
moneymorning.com news 50%
medicalxpress.com news 50%
en.protothema.gr news 50%
www.sciencenews.org news 50%
www.usatoday.com news 50%
www.wbur.org news 50%